[ET Net News Agency, 17 July 2019] IVD Medical Holding Limited (01931) said it is
expected that the group will record a significant increase in revenue by approximately
400% and a significant increase in profit attributable to owners of the parent of the
Group by approximately 650% (taking into account of the listing expenses incurred during
the six months ended 30 June 2019), respectively, for the six months ended 30 June 2019 as
compared to those for the six months ended 30 June 2018.
The increases were primarily attributable to (i) the consolidation of the financial
results of Vastec Medical Limited (Vastec) together with its subsidiaries after the
completion of the acquisition of 60% shareholding interest in Vastec in January 2019; and
(ii) a gain on remeasurement of previously held interest in Vastec of approximately RMB218
million relating to the acquisition. (RC)